{'52WeekChange': None,
 'SandP52WeekChange': None,
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 31.38,
 'askSize': 1000,
 'averageDailyVolume10Day': 8637,
 'averageVolume': 5976,
 'averageVolume10days': 8637,
 'beta': None,
 'beta3Year': None,
 'bid': 30.2,
 'bidSize': 800,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'companyOfficers': [],
 'currency': 'USD',
 'dayHigh': 32.59,
 'dayLow': 31.171,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': None,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 30.656115,
 'fiftyTwoWeekHigh': 34,
 'fiftyTwoWeekLow': 19,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': 'Loncar Investments',
 'fundInceptionDate': 1534204800,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': None,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': 'Exchange Traded Fund',
 'logo_url': '',
 'longBusinessSummary': 'The investment seeks to track the performance, before '
                        'fees and expenses, of the Loncar China BioPharma '
                        'Index (the index).\n'
                        ' Under normal circumstances, at least 80% of the '
                        'fund&#39;s total assets (exclusive of any collateral '
                        'held from securities lending) will be invested in the '
                        'component securities of the index or in depositary '
                        'receipts representing such component securities. The '
                        'index seeks to track the performance of a modified '
                        'equal-weighted portfolio of companies directly '
                        'involved in the growth of China&#39;s pharmaceutical '
                        'and biotech related industries. The fund is '
                        'non-diversified.',
 'longName': 'Loncar China BioPharma ETF',
 'market': 'us_market',
 'marketCap': None,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_571567405',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': None,
 'navPrice': 32.48,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': None,
 'open': 32.59,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': None,
 'phone': '202-551-8090',
 'previousClose': 32.5943,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': None,
 'quoteType': 'ETF',
 'regularMarketDayHigh': 32.59,
 'regularMarketDayLow': 31.171,
 'regularMarketOpen': 32.59,
 'regularMarketPreviousClose': 32.5943,
 'regularMarketPrice': 32.59,
 'regularMarketVolume': 6079,
 'revenueQuarterlyGrowth': None,
 'shortName': 'Loncar China BioPharma ETF',
 'startDate': None,
 'strikePrice': None,
 'symbol': 'CHNA',
 'threeYearAverageReturn': None,
 'totalAssets': 11498971,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 26.447561,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '6e517d99-3814-3eb2-bb78-2e7e80db6fd6',
 'volume': 6079,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'yield': 0.0013,
 'ytdReturn': None}